Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tadalafil and Finasteride may help treat aggressive melanoma.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

EGFR inhibitors for lung cancer can cause severe skin issues.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Piperonylic acid may help hair growth and treat hair loss.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Ruxolitinib can cause a delayed skin reaction on the nose.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

ICP5249 helps hair grow by activating a specific cell pathway.

Janus kinase inhibitors may help treat lichen planopilaris.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

mTOR may link different pathways in hair follicle tumor formation.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.